This company has shut down. Proof Diagnostics is no longer operating — its last tracked round was a Series A in 2022.
Explore the Startup GraveyardProof Diagnostics is a health technology company that develops a diagnostic test for the detection of coronavirus disease infection.
Proof Diagnostics has raised $45.0M in total funding. The most recent round was Series A. The last funding was announced in April 2022.
Proof Diagnostics's investors include SV Angel, ARCH Venture Partners, Madrona, F-Prime.
Proof Diagnostics is headquartered in Cambridge, United States.
Proof Diagnostics is a health technology company that develops a diagnostic test for the detection of coronavirus disease infection.
Proof Diagnostics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Proof Diagnostics — Funding & Investors." VCBacked, April 7, 2022, https://www.vcbacked.co/company/proof-diagnostics. Accessed July 20, 2026.
VCBacked. (2022). Proof Diagnostics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/proof-diagnostics
{{cite web |title=Proof Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/proof-diagnostics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated